Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: two case reports

Clin Chem Lab Med. 2020 Mar 26;58(4):e105-e108. doi: 10.1515/cclm-2019-0950.

¹ Immunology and Allergology Laboratory Unit, San Giovanni di Dio Hospital, Via Torregalli 3, 50143 Florence, Italy, Phone: +39 055 6932502, Fax: +39 055 6932289.
² Immunology and Allergology Laboratory Unit, San Giovanni di Dio Hospital, Florence, Italy.
³ Area Diagnostica di Laboratorio, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00164 Rome, Italy.
⁴ Dipartimento di Medicina di Laboratorio, Ospedale Madre Giuseppina Vannini, Rome, Italy.
⁵ Istituto di Patologia Generale, Università Cattolica del Sacro Cuore, Rome, Italy.
⁶ Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
⁷ Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy.
⁸ Rheumatology Unit, University of Messina, Messina, Italy.

No abstract available

Keywords: TNF; adalimumab; anti-TNF drugs; certolizumab; immunogenicity.

Publication types